Literature DB >> 23740770

The role of tyrosine sulfation in the dimerization of the CXCR4:SDF-1 complex.

Chaya Rapp1, Sara Snow, Talya Laufer, Christopher L McClendon.   

Abstract

Oligomerization of G protein-coupled receptors is a recognized mode of regulation of receptor activities, with alternate oligomeric states resulting in different signaling functions. The CXCR4 chemokine receptor is a G protein-coupled receptor that is post-translationally modified by tyrosine sulfation at three sites on its N-terminus (Y7, Y12, Y21), leading to enhanced affinity for its ligand, stromal cell derived factor (SDF-1, also called CXCL12). The complex has been implicated in cancer metastasis and is a therapeutic target in cancer treatment. Using molecular dynamics simulation of NMR-derived structures of the CXCR4 N-terminus in complex with SDF-1, and calculations of electrostatic binding energies for these complexes, we address the role of tyrosine sulfation in this complex. Our results show that sulfation stabilizes the dimeric state of the CXCR4:SDF-1 complex through hydrogen bonding across the dimer interface, conformational changes in residues at the dimer interface, and an enhancement in electrostatic binding energies associated with dimerization. These findings suggest a mechanism through which post-translational modifications such as tyrosine sulfation might regulate downstream function through modulation of the oligomeric state of the modified system.
© 2013 The Protein Society.

Entities:  

Keywords:  chemokine receptor; dimerization; molecular dynamics; post-translational modification; sulfotyrosine

Mesh:

Substances:

Year:  2013        PMID: 23740770      PMCID: PMC3832039          DOI: 10.1002/pro.2288

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  32 in total

1.  The Protein Data Bank.

Authors:  H M Berman; J Westbrook; Z Feng; G Gilliland; T N Bhat; H Weissig; I N Shindyalov; P E Bourne
Journal:  Nucleic Acids Res       Date:  2000-01-01       Impact factor: 16.971

2.  Electrostatics of nanosystems: application to microtubules and the ribosome.

Authors:  N A Baker; D Sept; S Joseph; M J Holst; J A McCammon
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-21       Impact factor: 11.205

3.  Computational analysis of PKA-balanol interactions.

Authors:  C F Wong; P H Hünenberger; P Akamine; N Narayana; T Diller; J A McCammon; S Taylor; N H Xuong
Journal:  J Med Chem       Date:  2001-05-10       Impact factor: 7.446

4.  A hierarchical approach to all-atom protein loop prediction.

Authors:  Matthew P Jacobson; David L Pincus; Chaya S Rapp; Tyler J F Day; Barry Honig; David E Shaw; Richard A Friesner
Journal:  Proteins       Date:  2004-05-01

5.  Backbone dynamics of SDF-1alpha determined by NMR: interpretation in the presence of monomer-dimer equilibrium.

Authors:  Olga K Baryshnikova; Brian D Sykes
Journal:  Protein Sci       Date:  2006-11       Impact factor: 6.725

6.  Recognition of a CXCR4 sulfotyrosine by the chemokine stromal cell-derived factor-1alpha (SDF-1alpha/CXCL12).

Authors:  Christopher T Veldkamp; Christoph Seibert; Francis C Peterson; Thomas P Sakmar; Brian F Volkman
Journal:  J Mol Biol       Date:  2006-05-11       Impact factor: 5.469

7.  Dimerization of CXCR4 in living malignant cells: control of cell migration by a synthetic peptide that reduces homologous CXCR4 interactions.

Authors:  Jinhai Wang; Liusheng He; Christian A Combs; Gregory Roderiquez; Michael A Norcross
Journal:  Mol Cancer Ther       Date:  2006-10       Impact factor: 6.261

Review 8.  Chemotaxis in cancer.

Authors:  Evanthia T Roussos; John S Condeelis; Antonia Patsialou
Journal:  Nat Rev Cancer       Date:  2011-07-22       Impact factor: 60.716

9.  The monomer-dimer equilibrium of stromal cell-derived factor-1 (CXCL 12) is altered by pH, phosphate, sulfate, and heparin.

Authors:  Christopher T Veldkamp; Francis C Peterson; Adam J Pelzek; Brian F Volkman
Journal:  Protein Sci       Date:  2005-03-01       Impact factor: 6.725

10.  Comparing Conformational Ensembles Using the Kullback-Leibler Divergence Expansion.

Authors:  Christopher L McClendon; Lan Hua; Abriela Barreiro; Matthew P Jacobson
Journal:  J Chem Theory Comput       Date:  2012-04-13       Impact factor: 6.006

View more
  6 in total

Review 1.  Role of tyrosine-sulfated proteins in retinal structure and function.

Authors:  Y Kanan; M R Al-Ubaidi
Journal:  Exp Eye Res       Date:  2015-04       Impact factor: 3.467

Review 2.  What Do Structures Tell Us About Chemokine Receptor Function and Antagonism?

Authors:  Irina Kufareva; Martin Gustavsson; Yi Zheng; Bryan S Stephens; Tracy M Handel
Journal:  Annu Rev Biophys       Date:  2017-05-22       Impact factor: 12.981

Review 3.  Sequencing Overview of Ewing Sarcoma: A Journey across Genomic, Epigenomic and Transcriptomic Landscapes.

Authors:  Laurens G L Sand; Karoly Szuhai; Pancras C W Hogendoorn
Journal:  Int J Mol Sci       Date:  2015-07-16       Impact factor: 5.923

4.  Decoding the Interactions Regulating the Active State Mechanics of Eukaryotic Protein Kinases.

Authors:  Hiruy S Meharena; Xiaorui Fan; Lalima G Ahuja; Malik M Keshwani; Christopher L McClendon; Angela M Chen; Joseph A Adams; Susan S Taylor
Journal:  PLoS Biol       Date:  2016-11-30       Impact factor: 8.029

5.  Fluorescent CXCR4 targeting peptide as alternative for antibody staining in Ewing sarcoma.

Authors:  Laurens G L Sand; Tessa Buckle; Fijs W B van Leeuwen; Willem E Corver; Alwine B Kruisselbrink; Aart G Jochemsen; Pancras C W Hogendoorn; Károly Szuhai
Journal:  BMC Cancer       Date:  2017-05-26       Impact factor: 4.430

6.  Dynamics at the serine loop underlie differential affinity of cryptochromes for CLOCK:BMAL1 to control circadian timing.

Authors:  Jennifer L Fribourgh; Ashutosh Srivastava; Colby R Sandate; Alicia K Michael; Peter L Hsu; Christin Rakers; Leslee T Nguyen; Megan R Torgrimson; Gian Carlo G Parico; Sarvind Tripathi; Ning Zheng; Gabriel C Lander; Tsuyoshi Hirota; Florence Tama; Carrie L Partch
Journal:  Elife       Date:  2020-02-26       Impact factor: 8.140

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.